CareLit · DOI-Nachweis · Pneumologie
Selective inhibition of chemokine CCL2/MCP-1 reduces experimental pulmonary hypertension
DOI 10.1055/s-0033-1345048
Bibliografische Angaben
Nachweis in CareLit
Autor:innenD Kosanovic, BK Dahal, C Vroom, E Bieniek, H Ardeschir Ghofrani, N Weissmann, W Seeger, F Grimminger, S Klussmann, D Eulberg, RT Schermuly
ZeitschriftPneumologie
Ausgabe05/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: It has been shown previously that the increased levels of pro-inflammatory infiltrates and accumulation of inflammatory cells are present in clinical and experimental pulmonary hypertension (PH), suggesting the role of inflammation in pulmonary vascular remodelling. Literature implicates the involvement of the chemokine CCL2/monocyte chemoattractant protein (MCP)-1 in PH development. This study aimed to…
Zitieren
Zitierempfehlung
D Kosanovic, BK Dahal, C Vroom, E Bieniek, H Ardeschir Ghofrani, N Weissmann, W Seeger, F Grimminger, S Klussmann, D Eulberg, RT Schermuly (2013) Selective inhibition of chemokine CCL2/MCP-1 reduces experimental pulmonary hypertension. Pneumologie (05). https://doi.org/10.1055/s-0033-1345048
Mit CareLit weiterarbeiten